<DOC>
	<DOCNO>NCT01725230</DOCNO>
	<brief_summary>A study Assess Pharmacokinetics Rosuvastatin Simvastatin administer alone combination Fostamatinib .</brief_summary>
	<brief_title>Assess Pharmacokinetics Rosuvastatin Simvastatin When Administered Alone Combination With Fostamatinib</brief_title>
	<detailed_description>An Open-label , Non-randomized , 2-Period , Fixed Sequence , Single-center Study Assess Pharmacokinetics Rosuvastatin Simvastatin Healthy Subjects Administered Alone Combination Fostamatinib 100 mg Twice Daily .</detailed_description>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Provision sign date , write informed consent , prior studyspecific procedure Volunteers male female age 18 55 year weight least 50 kg body mass index ( BMI ) 18 30 kg/m2 , inclusive . Male volunteer willing use barrier contraception , ie , condom , day first dose 2 week last dosing IP . Females must negative pregnancy test screen admission unit , must lactate , must non childbearing potential , confirm screening . History clinically significant disease disorder , opinion Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate study . History presence GI , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant illness , medical/surgical procedure , trauma within 4 week first administration IP judge Investigator . Any clinically significant abnormality clinical chemistry , hematology , urinalysis result judge Investigator . Any clinically significant abnormal finding vital sign judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Fostamatinib ,</keyword>
	<keyword>simvastatin ,</keyword>
	<keyword>rosuvastatin ,</keyword>
	<keyword>Phase I ,</keyword>
	<keyword>Healthy Subjects ,</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>